Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection.

Transplantation
Bong-Ha ShinMieko Toyoda

Abstract

Chronic antibody-mediated rejection (cAMR) results in the majority of renal allograft losses. Currently, there are no approved therapies. We recently reported on clinical use of tocilizumab (TCZ) for treatment of cAMR in HLA-sensitized kidney transplant patients. IgG1 and IgG3 subclasses of IgG are potent effectors of complement- and antibody-dependent cellular cytotoxicity, which are critical mediators of AMR. Here, we examined the impact of TCZ treatment for cAMR on total IgG, IgG1-4 subclasses, and anti-HLA-IgG (total and subclasses). Archived plasma obtained pre- and post-TCZ treatment (8 mg/kg, 6×, monthly) from 12 cAMR patients who failed standard of care treatment with intravenous immune globulin + rituximab with or without plasma exchange were tested for total IgG and IgG1-4 by ELISA, anti-HLA-total IgG, IgG3 and IgG4, and donor-specific antibody by Luminex assay. Archived plasma from 14 cAMR patients treated with the standard of care were included as controls. Total IgG and IgG1-3 were significantly reduced post-TCZ, whereas no reduction was seen post-treatment in the control group. Of 11 patients, 8 (73%) showed reduction of anti-HLA-total IgG and IgG3 post-TCZ, but this was not statistically significant. TCZ reduced ...Continue Reading

References

Jul 16, 2002·Annals of Clinical Biochemistry·G A MaguireH J Joyce
Sep 25, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Zu-hua GaoAllan S MacDonald
Mar 14, 2008·Journal of the American Society of Nephrology : JASN·Yael Nechemia-ArbelyJonathan H Axelrod
Mar 29, 2008·Annual Review of Immunology·Janet StavnezerCarol E Schrader
Jul 19, 2008·The New England Journal of Medicine·Ashley A VoStanley C Jordan
Feb 9, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Dominic Paquin ProulxRenée Bazin
Aug 24, 2010·Immunological Reviews·Michael J TownsendAndrew C Chan
Jun 15, 2011·Current Opinion in Organ Transplantation·Stanley C JordanAshley Vo
Jul 29, 2011·The New England Journal of Medicine·Robert A MontgomeryDorry L Segev
Nov 16, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J SellarésP F Halloran
Apr 18, 2012·Nature Reviews. Nephrology·Alexandre LoupyStanley C Jordan
Jan 1, 2011·Frontiers in Immunology·Thomas L Rothstein
Mar 16, 2013·International Journal of Biological Sciences·Gustavo CarboneMercedes Rincon
Feb 4, 2014·Transplantation·Matthew J EverlyPaul I Terasaki
Nov 5, 2014·Frontiers in Immunology·Gestur VidarssonTheo Rispens
Feb 11, 2015·Annals of the Rheumatic Diseases·Mollie N CarruthersJohn H Stone
Mar 17, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J G O'LearyP I Terasaki
Apr 22, 2015·Nature Immunology·Christopher A Hunter, Simon A Jones
May 4, 2015·British Medical Bulletin·Stanley C JordanAshley Vo
Aug 22, 2015·Journal of the American Society of Nephrology : JASN·Carmen LefaucheurAdriana Zeevi
Sep 9, 2015·Current Opinion in Organ Transplantation·Alessandro Amore
Aug 9, 2016·Critical Reviews in Oncology/hematology·Thomas MatthesBertrand Huard
Feb 16, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J ChoiS C Jordan
Dec 22, 2017·Transplantation·Nicole M Valenzuela, Stefan Schaub

❮ Previous
Next ❯

Citations

Jun 5, 2020·Journal of Nephrology·Fabio VistoliUNKNOWN the Joint Committee of the Italian Society of Organ Transplantation and the Italian Society of Nephrology
Jul 23, 2020·Therapeutics and Clinical Risk Management·Mahtabalsadat MirjaliliAfsaneh Vazin
Aug 31, 2020·Clinical Transplantation·Hernando TrujilloAmado Andrés
Dec 18, 2020·Current Opinion in Organ Transplantation·Ondrej ViklickyPetra Hruba
Dec 18, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sindhu ChandranFlavio G Vincenti
Jan 18, 2021·Clinical Transplantation·Puneet SoodSundaram Hariharan
Jan 15, 2021·Journal of the American Society of Nephrology : JASN·Konstantin DobererGeorg A Böhmig
Feb 5, 2021·Clinical & Translational Immunology·Peter RiddellStephen C Juvet
Apr 4, 2021·Journal of Clinical Medicine·Johan NobleThomas Jouve
May 4, 2021·Frontiers in Pharmacology·Min Young Kim, Daniel C Brennan
Nov 17, 2020·Transplantation·Edward John Filippone, John L Farber
Jun 4, 2021·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Thomas JouveLionel Rostaing
Jul 14, 2021·Immunological Reviews·Amy P RossiE Steve Woodle
Aug 28, 2021·Journal of Clinical Medicine·Danae OlasoJean Kwun
Sep 4, 2021·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Maria M CrespoAllan R Glanville
Jul 9, 2021·Kidney Research and Clinical Practice·Yohan ParkChul Woo Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
ELISA
antigen assay

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.